249 related articles for article (PubMed ID: 23601595)
1. Local drug delivery to prevent restenosis.
Seedial SM; Ghosh S; Saunders RS; Suwanabol PA; Shi X; Liu B; Kent KC
J Vasc Surg; 2013 May; 57(5):1403-14. PubMed ID: 23601595
[TBL] [Abstract][Full Text] [Related]
2. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
Trials; 2012 May; 13():55. PubMed ID: 22559260
[TBL] [Abstract][Full Text] [Related]
3. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
5. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in application of local drug delivery for preventing restenosis after peripheral arterial revascularization].
Zhang M; Zhang F; Zhang H; Liang G
Zhonghua Wai Ke Za Zhi; 2015 Mar; 53(3):237-40. PubMed ID: 26269021
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting balloon: the comeback kid?
Waksman R; Pakala R
Circ Cardiovasc Interv; 2009 Aug; 2(4):352-8. PubMed ID: 20031739
[No Abstract] [Full Text] [Related]
8. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
[TBL] [Abstract][Full Text] [Related]
9. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
10. Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.
Clever YP; Cremers B; von Scheidt W; Böhm M; Speck U; Scheller B
Clin Res Cardiol; 2014 Jan; 103(1):21-7. PubMed ID: 24072418
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial.
Chevalier B; Dimario C; Neumann FJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Coe J; Schwartz LB;
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1039-47. PubMed ID: 23592567
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; Otaegui I; Masotti M; Zueco J; Veláquez M; Sanchís J; García-Touchard A; Lázaro-García R; Moreu J; Bethencourt A; Cuesta J; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C;
JACC Cardiovasc Interv; 2016 Jun; 9(12):1246-1255. PubMed ID: 27339840
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study.
Pleva L; Kukla P; Kusnierova P; Zapletalova J; Hlinomaz O
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003316. PubMed ID: 27069104
[TBL] [Abstract][Full Text] [Related]
14. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
[TBL] [Abstract][Full Text] [Related]
15. Targeted vascular drug delivery. A new day for an old way.
Buchbinder M; Solar R
Panminerva Med; 2013 Dec; 55(4):353-61. PubMed ID: 24434344
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
17. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022
[TBL] [Abstract][Full Text] [Related]
19. Advances on drug-coated balloons.
Tepe G; Schmitmeier S; Speck U; Schnorr B; Kelsch B; Scheller B
J Cardiovasc Surg (Torino); 2010 Feb; 51(1):125-43. PubMed ID: 20081769
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
